content

Fusion Antibodies and Queens University Belfast Receive Invest Northern Ireland Grant to Boost Research and Development for COVID-19 Antibodies

Fusion Antibodies, pre-clinical antibody discovery, engineering and supply experts, and Queenโ€™s University Belfast, leader in innovation and impact, have been awarded a ยฃ453,000 grant...

Covid-19: Russia’s Sputnik V vaccine confirms 91.4% efficacy

Russiaโ€™s Sputnik V vaccine has demonstrated an efficacy of over 90 percent, according to the Gamaleya Center and the Russian Direct Investment Fund. โ€œEvaluation of...

Biogen Files New Drug Application for Aducanumab in Japan

Biogen and Eisai, Co., Ltd. announced that Biogen has submitted a Japanese New Drug Application (J-NDA) to the Ministry of Health, Labor and Welfare...

U.S. Government Exercises 1st Option for Additional 100 Million Doses of Moderna’s COVID-19 Vaccine Candidate

Moderna, Inc., a biotechnology company pioneering messenger RNA (mRNA) therapeutics and vaccines to create a new generation of transformative medicines for patients, announced that...

AstraZeneca reports Trixeo Aerosphere approved in EU for COPD maintenance

AstraZenecaโ€™s Trixeo Aerosphere has been approved in the European Union (EU) for maintenance treatment in adult patients with moderate to severe chronic obstructive pulmonary...

Roche launches laboratory SARS-CoV-2 antigen test to support high-volume testing of suspected COVID-19 patients

Roche announced that it has launched a high-throughput SARS-CoV-2 antigen test as an aid in the diagnosis of Severe Acute Respiratory Syndrome Coronavirus 2...

SpiceXpress strengthens pharma cold chain capabilities with Om partnership

SpiceXpress, the cargo division of India-based carrier SpiceJet, has partnered with Om Logistics to strengthen its capabilities to transport temperature-sensitive Covid-19 vaccines. The carrier said...

Subscribe

- Never miss a story with notifications

- Gain full access to our premium content

- Browse free from up to 5 devices at once

Must read